Screener
CONMED CNMD Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Gross profit | 197,458 | 188,320 | 380,905 | 366,071 |
| Selling and administrative expense | 145,553 | 136,021 | 287,252 | 284,868 |
| Research and development expense | 15,500 | 14,138 | 31,833 | 27,084 |
| Operating expenses | 161,053 | 150,159 | 319,085 | 311,952 |
| Income from operations | 36,405 | 38,161 | 61,820 | 54,119 |
| Interest expense | 7,883 | 7,824 | 14,943 | 16,110 |
| Other (income) / expense | (2,825) | 418 | (2,825) | 418 |
| Income before income taxes | 31,347 | 29,919 | 49,702 | 37,591 |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's total operating expenses?
- CONMED (CNMD) reported total operating expenses of $161.05M in Q2 2026.
- How has CONMED's total operating expenses changed year-over-year?
- CONMED's total operating expenses increased by 7.3% year-over-year, from $150.16M to $161.05M.
- What is the long-term trend for CONMED's total operating expenses?
- Over 4 years (2021 to 2025), CONMED's total operating expenses has grown at a 9.0% compound annual growth rate (CAGR), from $458.32M to $647.85M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about CONMED's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude